PET/MRI in Oncology

Introduction.- PET technology designs for PET/MRI.- MR hardware for PET/MR.- MR pulse sequences for PET/MR.- MR contrast agents.- PET/MRI: attenuation correction.- PET/MRI: motion correction.- PET/MRI: reliability/reproducibility of SUV measurements.- PET/MRI: Safety considerations.- Functional/Heterogeneity MR techniques in Oncology.- Workflow and protocols considerations.- Whole body applications.- Neuro: Brain Oncology.- Neuro: Head and Neck Oncology.- Lung nodules and lung cancer.- Breast cancer.- Liver - Tom.- Neuroendocrine tumors.- Oesophageal, Gastric, and Pancreatic Cancer.- Rectal cancer.- Gynecologic applications.- Prostate cancer.- Melanoma and multiple myeloma.- MSK oncology.- Lymphoma.- Pediatric oncology.- Future directions.

Dr. Iagaru is an Associate Professor of Radiology - Nuclear Medicine and the Co-Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford University Medical Center. He completed medical school at Carol Davila University of Medicine, Bucharest, Romania, and an internship at Drexel University College of Medicine, Graduate Hospital, in the Department of Medicine in Philadelphia. He began his residency at the University of Southern California (USC) Keck School of Medicine, Los Angeles, in the Division of Nuclear Medicine, where he was the chief resident. Dr. Iagaru finished his residency and completed a PET/CT fellowship at Stanford University's School of Medicine in the Division of Nuclear Medicine. His research interests include PET/MRI and PET/CT for early cancer detection; clinical translation of novel PET radiopharmaceuticals; peptide-based diagnostic imaging and therapy; radioimmunotherapy.Over the past seven years since joining the faculty at Stanford, Dr. Iagaru has received several awards including the Society of Nuclear Medicine (SNM) 2009 Image of the Year Award; American College of Nuclear Medicine (ACNM) Mid-Winter Conference 2010 Best Essay Award; 2009 Western Regional SNM Scientist Award; 2011 SNM Nuclear Oncology Council Young Investigator Award; and a Stanford Cancer Center 2009 Developmental Cancer Research Award in Translational Science. Dr. Iagaru presented more than 90 abstracts at national and international meetings and published more than 60 papers in peer-reviewed journals, as well as 7 book chapters.

Dr. Veit-Haibach is an Associate Professor of Radiology and Nuclear Medicine at the University Hospital in Zurich, Switzerland. He currently serves as the Section Head of the PET/CT-MR and PET/MR Unit in Zurich. He completed medical school at the University in Essen, Germany. During medical school, he completed internships/trainings in Germany, Switzerland, New Zealand and the United States. He started 100 papers in

"It is an updated and highly didactic text that is able to satisfy all the most important questions of people interested in the subject. ... All the chapters are written in a concise and clear style, and are therefore easily understandable by beginners, but still retaining the interest of experts. ... The major value of the book is the wide presentation of information achievable by the hybrid tool and by PET and MRI (also including fMRI) alone." (Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, 2019)

"This textbook represents a timely and succinct summary of the current scientific and clinical experience by a panel of world-leading experts on this topic to date. The book is compact and well-balanced. ... All the chapters are well-referenced. They are written in language that is unassuming and can be easily understood regardless of its readers' professional background ... . I would strongly recommend this book to anyone interested in the subject." (Simon Wan, RAD Magazine, August, 2018)

"It would be an asset to any training clinician in the core medical and surgical specialties who intends to pursue a career in oncology and haematology. It will be of particular benefit to training clinical and medical oncologists, who will find this book a useful reference for their future practice." (Andy Scarsbrook, British Journal of Hospital Medicine, Vol. 19 (6), June, 2018)